Conference
Society of Interventional Radiology (SIR)
The Society of Interventional Radiology annual scientific conference will take place in Toronto, Canada beginning on April 11, 2026. If
Accelerating life-saving cancer research
What we do
Sus Clinicals helps cancer researchers identify and accelerate their most promising cancer therapeutics.
Our proprietary Oncopig® platform helps advance drugs, devices and diagnostics, providing predictive preclinical data across a broad range of tumor models.
Service Delivery Models
Multiple Pathways to Oncopig Research
Sus Clinicals works with our clients to design research programs that fit their specific needs and existing infrastructure. We provide flexible engagement models whether you work with CRO partners or conduct studies in-house.
CRO Partnership Model
Our preferred service delivery approach leverages partnerships with top-tier clinical research organizations equipped with the expertise, facilities, and regulatory compliance needed for rigorous Oncopig studies.
- Expert study design and execution
- Regulatory compliance and documentation
- Comprehensive data and sample management
- AAALAC-accredited facilities
Direct Institution Supply
For academic and industry clients with established animal research facilities, we provide Oncopigs directly along with comprehensive training and ongoing technical support.
- Direct Oncopig supply and logistics
- Tumor induction training
- Methodology guidance and consultation
- On-site technical assistance available
European Research Services
Through our partnership with Versa Biomedical in Barcelona, we deliver localized Oncopig research services to clients in Europe, combining our platform expertise with regional infrastructure and expertise.
- Local European CRO expertise
- Streamlined logistics and compliance
- Sus Clinicals oversight and guidance
- Integrated scientific support
How We Work
We work with top-tier clinical research organizations (CROs) that have the expertise, facilities and equipment to successfully execute Oncopig studies.
Sus Clinicals recognizes that many clients have established relationships with CROs beyond our preferred partner network. We are committed to engaging with any qualified research organization and readily provide training, technical guidance, and support to ensure successful Oncopig-based research outcomes.
For academic and industry clients with established animal research facilities, we provide Oncopigs directly along with comprehensive training and ongoing technical support.
Upcoming events
Conference
American Association for Cancer Research (AACR)
The 2026 American Association for Cancer Research annual meeting will take place in San Diego, CA beginning on April 17,
News and publications
Press release
IBEX Preclinical Research and Sus Clinicals Announce Strategic Collaboration to Advance Medical Device Research
LOGAN, UT and CINCINNATI, OH, April 7, 2026 – IBEX Preclinical Research, a leading med tech CRO for preclinical surgical
Press release
MED Institute and Sus Clinicals Announce Strategic Collaboration to Advance Preclinical Testing for Medical Product Innovation
WEST LAFAYETTE, Ind.–(BUSINESS WIRE)–MED Institute, a leader in pre-clinical and clinical medical product development services, is proud to announce a
Press release
Sus Clinicals Announces New Chief Executive Officer
Experienced Pharmaceuticals and Oncology Executive to Assume Leadership Role Cincinnati, OH and Boston, MA, July 29, 2024 — Sus Clinicals,
About us
Sus Clinicals (“Sus” rhymes with “moose”) is named for the genus of wild and domestic pigs (Sus scrofa). We make use of the remarkable similarity between pigs and humans to help our healthcare client partners develop breakthrough therapeutics more efficiently and more quickly, helping to save lives.
Our proprietary large animal research platform is FDA-cleared and accelerates preclinical research. We aim to bridge the gap between fast but minimally predictive mouse-based testing and costly, time-consuming, and high-risk human clinical trials.
Our genetically-engineered Oncopig® enables testing of medical devices, diagnostics, and drugs to assess their potential efficacy, safety and/or metabolic effects. By inducing relevant tumors (and comorbidities if appropriate) on demand, we can then test therapeutics and secure data, images, samples or other information to help our clients advance their work to the next step.
Ready to Accelerate Your Research Program?
Contact us to discuss how Oncopig-based research services can advance your preclinical development needs.